Fujian Aonong Biological Technology Group Incorporation Limited (SHA:603363)

SHA:603363 Cash Flow Statement

Financials in millions CNY. Fiscal year is January - December.

Operating Activities

Fiscal Year	TTM	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021
Period Ending	Mar 31, 2026	Dec 31, 2025	Dec 31, 2024	Dec 31, 2023	Dec 31, 2022	Dec 31, 2021
Net Income	-154.01	77.62	579.35	-3,651	-1,038	-1,520
Depreciation & Amortization	472.83	472.83	832.55	1,235	1,290	1,042
Other Amortization	27.47	27.47	96.22	86.97	59.47	49.33
Loss (Gain) From Sale of Assets	-0.36	-0.36	-46.16	38.28	-2.56	2.38
Asset Writedown & Restructuring Costs	46.8	46.8	174.46	470.43	51.24	42.49
Loss (Gain) From Sale of Investments	32.4	32.4	-1,499	5.83	14.44	37.42
Provision & Write-off of Bad Debts	23	23	55.64	46.16	24.82	56.75
Other Operating Activities	788.5	328.5	188.72	874.16	791.48	555.47
Change in Accounts Receivable	-435.76	-435.76	-3,695	-301.33	-47.36	-146.7
Change in Inventory	-320.18	-320.18	455.31	2,073	-1,223	-1,290
Change in Accounts Payable	-94.15	-94.15	2,734	-15.19	796.91	1,640
Change in Other Net Operating Assets	-0.38	-0.38	0.73	55.74	51.82	54.48
Operating Cash Flow	381.31	152.94	-116.78	984.01	663.64	524.29
Operating Cash Flow Growth	-	-	-	48.27%	26.58%	29.13%

Investing Activities

Fiscal Year	TTM	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021
Period Ending	Mar 31, 2026	Dec 31, 2025	Dec 31, 2024	Dec 31, 2023	Dec 31, 2022	Dec 31, 2021
Capital Expenditures	-184.05	-232.9	-262.68	-511.77	-1,499	-2,709
Sale of Property, Plant & Equipment	5.48	4.69	164.82	78.18	13.83	12.06
Cash Acquisitions	-0.33	-0.33	-2.1	-56.54	-64.89	-63.45
Divestitures	64.24	64.29	29.8	246.99	-0.19	5.6
Investment in Securities	-3.7	-4.05	28.15	3.77	-98.41	-19.76
Other Investing Activities	-4.26	-2.76	2.94	-82.71	-54.61	-32.2
Investing Cash Flow	-122.62	-171.05	-39.07	-322.08	-1,703	-2,806

Financing Activities

Fiscal Year	TTM	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021
Period Ending	Mar 31, 2026	Dec 31, 2025	Dec 31, 2024	Dec 31, 2023	Dec 31, 2022	Dec 31, 2021
Long-Term Debt Issued	-	361.5	957.62	7,534	6,568	5,995
Long-Term Debt Repaid	-	-795.58	-1,403	-8,066	-6,440	-4,427
Net Debt Issued (Repaid)	-390.73	-434.08	-445.76	-532.77	127.84	1,568
Issuance of Common Stock	-	-	1,709	-	1,618	1,064
Repurchase of Common Stock	-7.1	-7.1	-35.64	-8.44	-61.82	-3.11
Common Dividends Paid	-80.75	-84.51	-76.39	-294.86	-373.67	-345.77
Other Financing Activities	10.31	-41.06	-15.22	-294.26	-89.69	-83.36
Financing Cash Flow	-468.26	-566.75	1,135	-1,130	1,220	2,200

Net Cash Flow

Fiscal Year	TTM	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021
Period Ending	Mar 31, 2026	Dec 31, 2025	Dec 31, 2024	Dec 31, 2023	Dec 31, 2022	Dec 31, 2021
Foreign Exchange Rate Adjustments	-0.06	-0.04	0	-2.06	-2.05	-0.11
Net Cash Flow	-209.62	-584.89	979.64	-470.46	178.55	-82.54

Free Cash Flow

Fiscal Year	TTM	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021
Period Ending	Mar 31, 2026	Dec 31, 2025	Dec 31, 2024	Dec 31, 2023	Dec 31, 2022	Dec 31, 2021
Free Cash Flow	197.26	-79.95	-379.46	472.23	-835.31	-2,184
Free Cash Flow Growth	-	-	-	-	-	-
Free Cash Flow Margin	2.22%	-0.94%	-4.33%	2.43%	-3.86%	-12.11%
Free Cash Flow Per Share	0.09	-0.03	-0.44	0.55	-1.08	-3.36
Levered Free Cash Flow	-508.66	-865.58	-2,317	527.61	-1,115	-1,244
Unlevered Free Cash Flow	-426.14	-776.08	-1,910	871.35	-799.01	-982.65

Additional Metrics

Fiscal Year	TTM	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021
Period Ending	Mar 31, 2026	Dec 31, 2025	Dec 31, 2024	Dec 31, 2023	Dec 31, 2022	Dec 31, 2021
Cash Interest Paid	22.56	22.56	19.48	67.44	21.16	29.12
Cash Income Tax Paid	70.94	78.82	69.39	108.27	99.93	85.41
Change in Working Capital	-855.32	-855.32	-498.22	1,878	-526.51	257.88

Data Source: S&P Global Market Intelligence Last updated: Mar 31, 2026

Financial data is provided by S&P Global Market Intelligence and updates within hours after each earnings release, which is every three months for this company.

Update frequency:

Quarterly

Last checked:

Jul 30, 2026

Data Sources Report a data error